MRMuhit Rana

Muhit Rana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhit Rana has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Highly sensitive HPLC-MS/MS quantitation of opioids and morphine glucuronides in wastewater using a mid-range triple quadrupole platform

    by Thomas Regan, Ian Riley, Muhit Rana, Pengfei Xie, Avni Argun

    Wastewater-based epidemiology (WBE) is an emerging tool for monitoring community-level opioid consumption, but widespread implementation remains limited by the need for ultra-trace detection in complex wastewater matrices. Many existing methods capable of parts-per-trillion (ppt) quantitation rely on high-end mass spectrometry platforms that are costly and technically demanding. Consequently, there remains a critical need for sensitive and scalable workflows that can be implemented using widely available LC-MS/MS instrumentation. Here, we present a highly sensitive and accessible HPLC-MS/MS method for opioid analysis using a SCIEX Triple Quad 3500, a mid-range triple quadrupole instrument. The method targets opioids and opioid metabolites relevant to WBE: morphine, morphine-3-glucuronide (M3G), morphine-6-glucuronide (M6G), norfentanyl, noroxycodone, methadone, and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP). A key methodological innovation of this workflow is the integration of aqueous reconstitution with large-volume injection following SPE enrichment, enabling ppt-level quantitation on a mid-range triple quadrupole platform. Reconstitution in 100% water improved chromatographic peak shape and signal intensity for polar glucuronide metabolites while allowing a 10-fold increase in injection volume without compromising chromatographic performance. Scheduled multiple reaction monitoring (MRM) further enhanced selectivity and sensitivity for structurally similar analytes, such as M3G and M6G. The method was validated using wastewater samples from the Greater Albany, NY region, demonstrating robust performance in complex matrices. The results establish a scalable framework for ppt-level opioid surveillance using widely accessible LC-MS/MS instrumentation. Importantly, the method enables ppt-level quantitation of opioid glucuronides on a mid-range triple quadrupole platform without requiring high-resolution or premium-tier instrumentation, improving the accessibility of wastewater-based epidemiology workflows.

  • Open Access

    An Ultrasensitive and Novel Gene Sensor to Monitor Gut Microbiome

    by Muhit Rana, Meredith Stewart, Marinelle Rodrigues, Erdal Toprak, Andrew Koh, Avni A. Argun

    Infections caused by multi-drug-resistant organisms (MDROs) pose a significant public health threat, responsible for over 2 million hospitalizations and 23,000 deaths annually in the United States. Microbiome dysbiosis (imbalance) is considered one of the main causes for MDRO colonization and the resulting infections. Rapid detection and intervention of MDRO outbreaks are crucial to alleviating strain on patients and healthcare facilities. Current diagnostic methods for MDRO detection are too slow and costly to provide the rapid MDRO detection necessary for patient care facilities. Here we present a rapid, accurate and cost-effective electrochemical sensor capable of MDRO detection down to ∼10 4 colony forming units (CFU)/g in mice and human stool samples. Our novel sensor utilizes probe-modified S creen- P rinted E lectrodes (SPEs) capable of hybridizing target gene sequences associated with MDROs. The resulting probe/target complex generates a unique and highly sensitive signal detectable down to 10 atto molar or 10 CFU/mL of target TEM-1 gene. The use of these pre-functionalized SPEs reduces individual sample analysis time to less than an hour. Several target sequences from two chromosomal target genes (AmpC and AcrB found in E. coli ) have been identified and successfully detected in clinical stool samples with results comparable to the standard quantitative PCR method. Additional target genes associated with antibiotic resistance ( TEM-1, VanA, KPC and SHV ) have also been successfully detected in vitro and are ready for clinical evaluation. Future development includes multiplexing the sensor to simultaneously detect up to three MDROs target genes, including β-lactamases that hydrolyze β-lactams, the most commonly used antibiotics in clinical settings. This novel sensor platform will be a rapid, economical, point-of-care device with little requirement of reagent handling or technical training.

  • Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension

    by Riajul Wahab, Ali Keshavarz, Zulfikar Azam, Tamanna Islam, Mahedi Hasan, Xiaojun Zhang, Ahmed Alobaida, Muhit Rana, Jeong Uk Choi, Farzana Alam, et al.


  • Open Access

    A Novel Biosensor for Ultrasensitive Detection of Fungal Genes

    by Muhit Rana, Tugba Yilmaz, Shirli Cohen, Sinem Beyhan, Avni Argun

    Fungal infections are a rapidly increasing public health problem due to their high morbidity and mortality rates, especially in populations with compromised immune systems. Rapid and accurate diagnosis of these diseases is, therefore, necessary to improve the prognosis of afflicted patients. Unfortunately, current clinical chemistry practice relies on lengthy culturing methods that are insufficient to meet the fast turnaround requirements. Here we present a cost-effective and robust nucleic acid sensor that can identify the presence of histoplasmosis causing fungal genes, in whole blood or Bronchoalveolar lavage (BAL) samples, far earlier than current methods. Our novel assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of Hcp100, CBP1, and M antigen genes through electrochemical analysis. The resultant current is attributed to the presence of fungal targets in the sample solution. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 aM, sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is less than 90 minutes compared to the current clinical procedure’s turnaround time of 3-4 weeks.

  • Open Access

    A Novel Electrochemical Assay to Detect Fungal Genes

    by Muhit Rana, Tugba Yilmaz, Shirli Cohen, Sinem Beyhan, Avni Argun

    Rapid and accurate diagnosis of fungal diseases is an urgent medical need. The public health impact of fungal infections is on the increase due to high morbidity and mortality, especially in immune-compromised patients. Unfortunately, current medical diagnostics outside of lengthy culturing methods are insufficient to meet clinical requirements. The overall goal of this study is to develop a cost-effective and robust nucleic acid sensor that can rapidly and accurately identify the presence of Histoplasma-specific fungal genes to yield an early and definitive diagnosis of histoplasmosis. Our assay involves the hybridization of target gene sequences with immobilized nucleic acid probes, allowing direct, label-free detection of target organisms using an electrochemical output signal. The resultant current is attributed to the presence of fungal target genes in the sample solution, specifically Hcp100 , CBP1 , or M antigen. The assay provides ultra-sensitive detection of DNA molecules with a limit of detection (LOD) values down to 100 attomolar (aM), sufficient to meet the clinical diagnostic need. In addition, the turnaround time for the sample to result is relatively fast (≤90 mins). We have successfully developed this electrochemical assay capable of rapid, highly specific, and sensitive detection of Histoplasma specific genes in whole blood and Bronchoalveolar lavage (BAL) samples.